These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 19686290
1. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap. Nasir S, Klimczak A, Sonmez E, Bozkurt M, Gibson S, Siemionow M. Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290 [Abstract] [Full Text] [Related]
3. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Yoder B, Siemionow M. Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [Abstract] [Full Text] [Related]
4. Role of thymus in operational tolerance induction in limb allograft transplant model. Siemionow M, Izycki D, Ozer K, Ozmen S, Klimczak A. Transplantation; 2006 Jun 15; 81(11):1568-76. PubMed ID: 16770246 [Abstract] [Full Text] [Related]
5. Large antigenic skin load in total abdominal wall transplants permits chimerism induction. Nasir S, Bozkurt M, Klimczak A, Siemionow M. Ann Plast Surg; 2008 Nov 15; 61(5):572-9. PubMed ID: 18948789 [Abstract] [Full Text] [Related]
6. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies. Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Siemionow M. Ann Plast Surg; 2006 Mar 15; 56(3):295-300. PubMed ID: 16508361 [Abstract] [Full Text] [Related]
7. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier. Siemionow MZ, Klimczak A, Unal S. Transplant Proc; 2005 Mar 15; 37(1):62-4. PubMed ID: 15808547 [Abstract] [Full Text] [Related]
8. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II. Klimczak A, Agaoglu G, Carnevale KA, Siemionow M. Ann Plast Surg; 2006 Oct 15; 57(4):422-30. PubMed ID: 16998336 [Abstract] [Full Text] [Related]
9. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation. Siemionow M, Ulusal BG, Ozmen S, Ulusal AE, Ozer K. Microsurgery; 2004 Oct 15; 24(3):200-6. PubMed ID: 15160378 [Abstract] [Full Text] [Related]
10. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol. Siemionow M, Oke R, Ozer K, Izycki D, Prajapati R. J Hand Surg Am; 2002 Nov 15; 27(6):1095-103. PubMed ID: 12457363 [Abstract] [Full Text] [Related]
11. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation. Lin JY, Tsai FC, Wallace CG, Huang WC, Wei FC, Liao SK. J Surg Res; 2012 Nov 15; 178(1):487-93. PubMed ID: 22484382 [Abstract] [Full Text] [Related]
12. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow. Suzuki H, Patel N, Matthews M, DelRossi AJ, Doolin EJ, Hewitt CW. J Surg Res; 2000 Apr 15; 89(2):176-83. PubMed ID: 10729247 [Abstract] [Full Text] [Related]
13. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Siemionow MZ, Izycki DM, Zielinski M. Transplantation; 2003 Dec 27; 76(12):1662-8. PubMed ID: 14688512 [Abstract] [Full Text] [Related]
14. A new method of bone marrow transplantation leads to extension of skin allograft survival. Siemionow M, Ozer K, Izycki D, Unsal M, Klimczak A. Transplant Proc; 2005 Jun 27; 37(5):2309-14. PubMed ID: 15964406 [Abstract] [Full Text] [Related]
15. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival. Ramirez AE, Cheng HY, Lao WW, Wang YL, Wen CJ, Wallace CG, Lin CF, Shih LY, Chuang SH, Wei FC. Transpl Int; 2014 Sep 27; 27(9):977-86. PubMed ID: 24861714 [Abstract] [Full Text] [Related]
16. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers. Okayama J, Ko S, Kanehiro H, Kanokogi H, Nakajima Y. J Surg Res; 2006 Jun 15; 133(2):61-8. PubMed ID: 16376943 [Abstract] [Full Text] [Related]
17. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. Okayama J, Ko S, Kanehiro H, Kanokogi H, Hisanaga M, Ohashi K, Sho M, Nagao M, Ikeda N, Kanamura T, Akashi S, Nakajima Y. J Surg Res; 2004 Jul 15; 120(1):102-10. PubMed ID: 15172196 [Abstract] [Full Text] [Related]
18. Composite osseomusculocutaneous sternum, ribs, thymus, pectoralis muscles, and skin allotransplantation model of bone marrow transplantation. Bozkurt M, Klimczak A, Nasir S, Zor F, Krokowicz L, Siemionow M. Microsurgery; 2013 Jan 15; 33(1):43-50. PubMed ID: 22821819 [Abstract] [Full Text] [Related]
19. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols. Ozer K, Izycki D, Zielinski M, Siemionow M. Microsurgery; 2004 Jan 15; 24(3):248-54. PubMed ID: 15160385 [Abstract] [Full Text] [Related]
20. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Transplantation; 1995 Nov 15; 60(9):971-80. PubMed ID: 7491703 [Abstract] [Full Text] [Related] Page: [Next] [New Search]